Analysis was done using an unpaired, non-parametric Wilcoxons test (MannWhitney-U-test) if data was not normally distributed and unpaired t-test with Welchs correction if normally distributed
In Italia il farmaco atteso tra ottobre e novembre 2026, con lo stesso nome commerciale
The good news is that cognitive symptoms often improve as intracranial pressure is brought under control with treatment and weight loss
According to the company's FAQ, you'll provide information about your current weight, height, medical conditions, medications, and weight loss goals
Expectation Management Successful GLP-1 treatment requires commitment to lifestyle modifications alongside medication therapy
These actions can lower your insulin resistance and help keep your blood sugar levels in check